CB2 Receptors and Neuron–Glia Interactions Modulate Neurotoxicity Generated by MAGL Inhibition
Monoacylglycerol lipase inhibition (MAGL) has emerged as an interesting therapeutic target for neurodegenerative disease treatment due to its ability to modulate the endocannabinoid system and to prevent the production of proinflammatory mediators. To obtain a beneficial response, it is necessary to...
Main Authors: | Estefania Rojo-Bustamante, Ignacio Íñigo-Marco, Miguel Angel Abellanas, Rodrigo Vinueza-Gavilanes, Ana Baltanás, Esther Luquin, Montserrat Arrasate, Maria S. Aymerich |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/10/8/1198 |
Similar Items
-
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
by: Carlotta Granchi, et al.
Published: (2017-01-01) -
Cannabinoids & Stress: The Impact of Endogenous and Exogenous Cannabinoids on Anxiety Behaviors In an Acute Stress Model
by: Kinden, Renee
Published: (2015) -
Set-Up and Validation of a High Throughput Screening Method for Human Monoacylglycerol Lipase (MAGL) Based on a New Red Fluorescent Probe
by: Matteo Miceli, et al.
Published: (2019-06-01) -
New Disulfiram Derivatives as MAGL-Selective Inhibitors
by: Ziad Omran
Published: (2021-05-01) -
Brain CB2 Receptors: Implications for Neuropsychiatric Disorders
by: Michelle Roche, et al.
Published: (2010-08-01)